Angiolutions

Let’s meet in New York! We are attending the VEITH Symposium in New York from November 20-23. Join us for a coffee, and let’s explore how we can advance aortic medicine together. We look forward to meeting up – contact us on Linkedin to arrange a chat! Isabel N. Schellinger, Uwe Raaz, Marius Rummel

“Bridging Bench and Business: The Angiolutions Journey from Basic Science to Startup” was the title of our CEO Dr. Isabel N. Schellinger’s presentation at the joint meeting of the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation funded CRC research consortia and their graduate schools focussing on cardiac, kidney and vascular research in Frankfurt. Her main takeaway: “Look for the unmet clinical need, be brave, focus on execution and assemble a strong team with different skills. Most importantly: get started!”  Find out more about the event: https://lnkd.in/duPrUzQS

Angiolutions moves closer to providing patients with a new treatment for abdominal aortic aneurysms. True innovation is what sets us apart in this space. This is highlighted by the granting of our next U.S. patent. Read more at: https://lnkd.in/dBKBX2Xv

How will Angiolutions change vascular medicine? Our co-founder and CEO Isabel N. Schellinger was recently interviewed by the Rocketing Healthcare podcast and shared her journey from clinician scientist to entrepreneur. Listen to the full episode (in German) here: https://lnkd.in/d9saKjK4 

Meet our Chief Business Officer Marius Rummel at the Startup Germany Summit on September 17 in Berlin! About the event: https://lnkd.in/egniSjDG #StartUpGermanySummit

At Angiolutions we are pioneering the development of the world's first implant designed to stop abdominal aortic aneurysms at an early stage. As we prepare for clinical trials next year and look ahead to scaling production post-commercial launch, we recognize the importance of strong partnerships.  MeKo Manufacturing has been an exceptional partner throughout this journey. Renowned for their high-precision laser material processing, Meko combines speed and entrepreneurial spirit and has supported us every step of the way. In the picture: Meko CEO Jakob Dohse, our account manager and talented engineer Markus Binder, together with the Angiolutions leadership team Isabel N. Schellinger, Uwe Raaz, and Marius Rummel.

We are excited to introduce the Angiolutions Advisory Board! Each member brings a wealth of knowledge and experience to our mission of delivering the first implant designed to treat abdominal aortic aneurysms at an early stage. Meet our board members: Ruti Alon, Prof. Lars Maegdefessel, Eileen Rose, Prof. Dr. med. Hubert Schelzig, Dr. Hannah Teichmann, Prof. Phil Tsao Get to know the board members at: https://lnkd.in/dBCuxvx5 The picture shows our board and leadership team at a recent meeting in Germany.

What makes aneurysms grow and how can we stop them early? Very interesting presentation from Priv.- Doz. Dr. med. Markus Wagenhäuser – thanks for mentioning us in your post! 

This week, we have something to celebrate: Angiolutions won first prize at the START HEALTHCARE startup competition at #MedtecLIVE! The journey as a #MedTech startup is full of challenges – receiving this endorsement strengthens us on our mission to bring the first early-stage treatment to stop abdominal aortic aneurysms to patients! A big thank you to Medical Valley EMN e. V., Kurt Höller, Flying Health, gesundheit.digital.forum, MedtecLIVE and the jury members Alexander Rehn, Gerhard Lesch, Marco Wendel, Ann-Kathrin von Knobloch (Weigand), Matthias Schwarz, Christian Dorn and Jan Engels!

Next week, we'll be at the HTGF Family Day 2024! Our CEO and co-founder Isabel N. Schellinger and our CBO Marius Rummel, are looking forward to insightful conversations and discovering new opportunities together with you. Find out more at: https://lnkd.in/eY7nNXt HTGF | High-Tech Gründerfonds